FCCC LOGO Faculty Publications
Connolly DC , Hensley HH
Xenograft and Transgenic Mouse Models of Epithelial Ovarian Cancer and Non Invasive Imaging Modalities to Monitor Ovarian Tumor Growth In situ -Applications in Evaluating Novel Therapeutic Agents
Curr Protoc Pharmacol. 2009 Jun 1;45 :14 12 1-14 12 26
PMID: 20634901    PMCID: PMC2904083   
Back to previous list
Epithelial ovarian cancer (EOC) is the most commonly fatal gynecologic malignancy in developed countries. Most EOC patients are diagnosed at advanced stage when disease has spread beyond the ovary. While many patients initially respond to surgery and chemotherapy, the long term prognosis is generally unfavorable, with recurrence and development of drug resistant disease. There is a critical need to identify new therapeutic agents that prolong disease-free intervals and effectively manage recurrent disease. Murine models of ovarian carcinoma are excellent models to study tumor biology in the search for new treatments for EOC. Described in this unit are methods for establishing xenograft or allograft models of EOC using ovarian carcinoma cell lines, in vivo imaging strategies for detection and quantification of EOC in transgenic and in xenograft/allograft models, and procedures for necropsy and pathological evaluation of experimental animals.
P30 CA006927-47S1/NCI NIH HHS/United States P50 CA083638-08/NCI NIH HHS/United States P50 CA083638-09/NCI NIH HHS/United States Current protocols in pharmacology / editorial board, S.J. Enna (editor-in-chief) ... [et al.] Curr Protoc Pharmacol. 2009 Jun 1;45:14.12.1-14.12.26.